This inventor holds 1 USPTO granted patent. Top assignee: Quantamatrix Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Hyejin Kim - Innovator in Bioactivity Testing Structures
Introduction
Hyejin Kim is a notable inventor based in Cheongju-si, South Korea. She has made significant contributions to the field of bioactivity testing, particularly in the area of single cell tracking. Her innovative work has the potential to enhance diagnostic methods and drug susceptibility testing.
Latest Patents
Hyejin Kim holds 1 patent for her invention titled "Bioactivity testing structure for single cell tracking using gelling agents." This patent describes a novel bioactivity testing structure that facilitates rapid and simple drug susceptibility testing of bacteria. The invention allows for effective diagnosis and drug susceptibility testing of tuberculosis without the need for concentrating human sputum samples, ensuring accuracy and efficiency compared to conventional methods.
Career Highlights
Hyejin Kim is currently associated with Quantamatrix Inc., where she continues to develop her innovative ideas. Her work focuses on improving bioactivity testing systems, which are crucial for medical diagnostics and treatment strategies.
Collaborations
Hyejin collaborates with talented individuals such as Yong-Gyun Jung and Eun Guen Kim, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hyejin Kim's contributions to bioactivity testing represent a significant advancement in medical diagnostics. Her innovative patent offers a promising alternative to traditional methods, showcasing her dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile